Today: 9 June 2026
National Grid share price rises in London as €650m green bond terms land, Ofgem decision in view
4 February 2026
1 min read

National Grid share price rises in London as €650m green bond terms land, Ofgem decision in view

London, Feb 4, 2026, 08:53 GMT — Regular session

  • National Grid shares inched up roughly 0.6% during early trading in London
  • UK transmission unit unveiled final terms for a €650 million green bond
  • Investors remain focused on Ofgem’s forthcoming decisions regarding network licence changes

National Grid shares ticked up in early London trading Wednesday, buoyed by a stronger market and news from its UK electricity transmission arm. The unit unveiled final terms for a euro-denominated green bond. The stock gained roughly 0.6% to 1,264 pence, up from Tuesday’s close of 1,256 pence.

The shift is modest, yet it comes during a week when investors refocus on funding costs for regulated utilities. National Grid’s extensive grid expansion projects in Britain and the northeastern U.S. usually make their presence felt in debt markets.

National Grid Electricity Transmission plc has released final terms for a EUR 650 million senior green bond, carrying a 3.563% coupon and maturing on Feb. 3, 2034. The issuance falls under the group’s €20 billion medium-term note programme and has received approval from Britain’s Financial Conduct Authority.

Green bonds are straightforward debt instruments, but with a catch: the funds raised must go toward projects that fit specific environmental standards. In the utilities sector, that typically involves upgrading grids to support renewables and electrification efforts.

Regulation also remains in flux. This week, Britain’s energy watchdog Ofgem launched a consultation on RIIO-2 re-opener licence changes, with a deadline for responses set for March 2.

This matters because the regulator, not daily demand swings, largely sets allowed returns and incentives. It also means the stock can move on minor tweaks to the expected rules, even if operational updates are scarce.

National Grid’s stock got a boost as the FTSE 100 climbed roughly 0.6% around the same time. The company, part of a defensive segment of the index, tends to attract buyers when investors turn cautious.

The risk on the downside remains clear. Should rates climb once more or the regulator adopt a tougher stance that cuts cash returns beyond what investors anticipate, utilities could swiftly lose their appeal as a “bond proxy.”

Ofgem’s call on the licence changes is set for February, with National Grid planning to respond in early March, the company noted.

Stock Market Today

  • Soybean Prices Decline Amid Lower Export Shipments and Reduced Speculative Positions
    June 9, 2026, 9:21 AM EDT. Soybean prices fell between 2 and 5 ½ cents on Monday, with the national average cash price dropping to $10.58 3/4 per bushel. Export shipments for the week ending June 4 decreased by 21.2% from the previous week, totaling 398,186 MT, and are down 28.8% year-over-year. Key buyers included Egypt, China, and Mexico. Marketing year exports stand 20.3% lower compared to last year. Meanwhile, speculative traders reduced their net long positions in soybean futures and options by 33,502 contracts, signaling cautious market sentiment. Soymeal and soy oil futures also declined modestly. A private export sale of 264,000 MT was reported for the 2026/27 season, but overall market pressure weighs on prices going into the week.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
CoreWeave stock snaps back after lawsuit reminder and insider sale notice hit the tape
Previous Story

CoreWeave stock snaps back after lawsuit reminder and insider sale notice hit the tape

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM
Next Story

Sage Group share price slips again: AI selloff hits SGE.L ahead of AGM

Go toTop